Our observation of increased expression of GFAP, a marker of tumor cell maturation, and reduced expression of Ki-67, associated with cell proliferation, in mCEUS treated brains relative to non-mCEUS treated controls suggests that ultrasound under certain conditions can help temozolomide go through the BBB to better treat glioblastoma. The gene discussed is GFAP; the disease is glioblastoma.